×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
LS53 Application of RWD to Clinical Development: Discussion with Industry, Regulatory, and Academia Through Hypothetical Case Studies
Session Chair(s)
Takashi Moriya, PhD, MBA
Director, Vaccines, Real-World Evidence and Health Outcomes Research
GlaxoSmithKline K.K., Japan
Speaker(s)
Yoshifumi Ukyo
Janssen Pharmaceutical K.K., Japan
Associate Director, Statistics & Decision Sciences
Junichi Asano, PhD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Statistical Reviewer
Shogo Nomura, PhD
The University of Tokyo, Japan
Statistician, Department of Biostatistics
Have an account?